Business Type: Manufacturer, Trading Company, Buying Office, Agent, Distributor/Wholesaler, Government ministry/Bureau/Commission, Association, Business Service (Transportation, finance, travel, Ads, etc), Other
Employees Total
Annual Revenue
Cabozanix 20mg (Cabozantinib) is a generic kinase inhibitor indicated for the treatment of patients with progressive, metastatic medullary thyroid cancer.